Statistics

About Us | General

www.lostam-biopharma.com/

Lostam BioPharmaceuticals Ltd is a new Israeli start-up company that is developing a novel class of protein therapeutics (â€œbiologicsâ€) aimed to prevent ...

Lostam-biopharma.com

Conversion Technology Metas Server

Lostam-biopharma.com is hosted in United States / Houston . Lostam-biopharma.com uses HTTPS protocol. Number of used technologies: 5. First technologies: CSS, Html, Javascript, Number of used javascripts: 7. First javascripts: Mootools.js, Caption.js, Fusion.js, Number of used analytics tools: 1. First analytics tools: Google Analytics, Number of used plugins, modules: 2. Its server type is: nginx/1.8.1.

Technologies in use by Lostam-biopharma.com

Technology

Number of occurences: 5

CSS
Html
Javascript
MooTools
Php

Javascripts

Number of occurences: 7

mootools.js
caption.js
fusion.js
rokfonts.js
rokutils.js
rokutils.inputs.js
rokslideshow.js

Analytics

Number of occurences: 1

Google Analytics

Server Type

nginx/1.8.1

Social

Number of occurences: 1

Facebook Box

Used plugins, modules

Number of plugins and modules: 2

mod roknavmenu
mod rokslideshow

Conversion rate optimization
Clickable call number	Not founded!
Conversion form (contact form, subcriber)	Not founded!
Clickable email	Not founded!
CTA (call to action) button	Founded!
List	Founded!
Image	Not founded!
Enhancement	Not founded!
Responsive website	Not founded!
Facebook sharing	Not founded!
Google+ sharing	Not founded!
Twitter sharing	Not founded!
Linkedin sharing	Not founded!
Blog on the webiste	Not founded!

HTTPS (SSL) - Lostam-biopharma.com

SSL certificate

name: /OU=Domain Control Validated/OU=Hosted by HostGator.com, LLC./OU=PositiveSSL Wildcard/CN=*.websitewelcome.com
subject:
- OU:
  - 0: Domain Control Validated
  - 1: Hosted by HostGator.com, LLC.
  - 2: PositiveSSL Wildcard
- CN: *.websitewelcome.com
hash: b86b2c33
issuer:
- C: GB
- ST: Greater Manchester
- L: Salford
- O: COMODO CA Limited
- CN: COMODO RSA Domain Validation Secure Server CA
version: 2
serialNumber: 73802823338622261546480845931487065049
validFrom: 151016000000Z
validTo: 181015235959Z
validFrom_time_t: 1444953600
validTo_time_t: 1539647999
extensions:
- authorityKeyIdentifier: keyid:90:AF:6A:3A:94:5A:0B:D8:90:EA:12:56:73:DF:43:B4:3A:28:DA:E7
- subjectKeyIdentifier: 11:37:8F:56:DC:AF:E0:18:CB:07:A7:02:00:3C:DE:8C:B8:11:F4:3A
- keyUsage: Digital Signature, Key Encipherment
- basicConstraints: CA:FALSE
- extendedKeyUsage: TLS Web Server Authentication, TLS Web Client Authentication
- certificatePolicies: Policy: 1.3.6.1.4.1.6449.1.2.2.7 CPS: https://secure.comodo.com/CPS Policy: 2.23.140.1.2.1
- crlDistributionPoints: Full Name: URI:http://crl.comodoca.com/COMODORSADomainValidationSecureServerCA.crl
- authorityInfoAccess: CA Issuers - URI:http://crt.comodoca.com/COMODORSADomainValidationSecureServerCA.crt OCSP - URI:http://ocsp.comodoca.com
- subjectAltName: DNS:*.websitewelcome.com, DNS:websitewelcome.com

Meta - Lostam-biopharma.com

Number of occurences: 5

Name:
Content: text/html; charset=utf-8
Name: robots
Content: index, follow
Name: keywords
Content: Lostam, protein therapeutics, biologics, antibiotics, bacterial infections, hospital-acquired infections, anti-bacterial drugs, MDR, drug resistance, drug resistant bacteria,immune-suppressed patients,ESKAPE pathogens, ESKAPE, Lewis Neville, Nurit Rachamim
Name: author
Content: Eliahu
Name: description
Content: Lostam BioPharmaceuticals Ltd is a new Israeli start-up company that is developing a novel class of protein therapeutics (â€œbiologicsâ€) aimed to prevent and treat lethal bacterial infections associated primarily with the hospital setting. There are an estimated nine million hospital-acquired infections annually in the USA that can result in high mortalities, especially in patients with hampered immune systems. Consequently, there is an urgent need to design and develop novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the â€œcunningâ€ efforts of bacteria to develop drug- resistant mechanisms. Lostam BioPharmaceuticals Ltd was founded by Dr. Lewis Neville, an experienced scientific researcher with expertise in various disciplines of biochemistry, pharmacology, molecular biology and animal models of disease. The company operates within the framework of the New Generation Technology (NGT) technology incubator located in Nazareth, approximately 100 km NE of Tel Aviv.

Server / Hosting

IP: 192.185.170.253
Latitude: 29.83
Longitude: -95.47
Country: United States
City: Houston

Rname

ns783.websitewelcome.com
ns784.websitewelcome.com
lostam-biopharma.com

Target

varda.sigalon.com

HTTP Header Response

HTTP/1.1 301 Moved Permanently Server: nginx/1.8.1 Date: Mon, 25 Apr 2016 12:05:36 GMT Content-Type: text/html Connection: keep-alive P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM" Set-Cookie: 30790389c902e26308461d3f59b205ca=ef41659f91102abd24548fb7ef09e03f; path=/ Location: http://www.lostam-biopharma.com/ HTTP/1.1 200 OK Server: nginx/1.8.1 Date: Mon, 25 Apr 2016 12:05:37 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive P3P: CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM" Expires: Mon, 1 Jan 2001 00:00:00 GMT Cache-Control: post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: 30790389c902e26308461d3f59b205ca=5c7082e975a752c8567daef226c54507; path=/ Last-Modified: Mon, 25 Apr 2016 12:05:37 GMT